Timolol Maleate Solution
Product Images NDC 82260-818

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Timolol Maleate (NDC 82260-818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Americas Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem (Image 01)

FDA Label Image

.5 Carton (Image 02)

FDA Label Image

Graphs (Image 04)

FDA Label Image

Graph2 (Image 05)

This is a report of a clinical trial involving two different formulations of Timolol Maleate for treating ocular hypertension. The trial involved 226 patients and lasted for several weeks. The results are presented in a table that shows the average intraocular pressure readings at two different times of day (trough and peak). Not enough context is provided to determine the specific results or methodology of the trial.*

FDA Label Image

Timoptic-xe_ifu_fig A (Image 06)

FDA Label Image

Timoptic-xe_ifu_fig B (Image 07)

FDA Label Image

Timoptic-xe_ifu_fig C (Image 08)

FDA Label Image

.25 Carton (Image 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.